{"DataElement":{"publicId":"2649487","version":"1","preferredName":"AIDS Malignancy Consortium Patient Exclusion Clinical Trial Eligibility Criteria 051 Type","preferredDefinition":"the type of element of a personal medical history which are necessary to allow an individual to participate in a specific clinical trial of a person who receives medical attention, care, or treatment in a clinical trials cooperative group supported by NCI.","longName":"AMC_PT_E_CTEC_051_TP","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2518234","version":"1","preferredName":"AIDS Malignancy Consortium Patient Exclusion Clinical Trial Eligibility Criteria","preferredDefinition":"information relating to the elements of a personal medical history which are necessary to allow an individual to participate in a specific clinical trial of a person who receives medical attention, care, or treatment in a clinical trials cooperative group supported by the NCI.","longName":"AMC_PT_EXCLU_CTEC","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2518228","version":"1","preferredName":"AIDS Malignancy Consortium Patient","preferredDefinition":"Established in 1995 to carry out Phase I and II studies of innovative therapies for AIDS malignancies.:A person who requires medical care.","longName":"C19707:C16960","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"AIDS Malignancy Consortium","conceptCode":"C19707","definition":"Established in 1995 to carry out Phase I and II studies of innovative therapies for AIDS malignancies.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Patient","conceptCode":"C16960","definition":"A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1CC96D39-08C6-6793-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-09-06","endDate":null,"createdBy":"SHIDED","dateCreated":"2006-09-06","modifiedBy":"ONEDATA","dateModified":"2006-09-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2518232","version":"1","preferredName":"Exclusion Clinical Trial Eligibility Criteria","preferredDefinition":"Exclusion; the act of restricting entrance or barring from participation.:Elements of a personal medical history which are necessary to allow an individual to participate in a specific clinical trial.","longName":"C25370:C16112","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Exclusion Criteria","conceptCode":"C25370","definition":"Medical and/or social characteristics that prevent a subject from being allowed to participate in a clinical study, as outlined in the study protocol.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Clinical Trial Eligibility Criteria","conceptCode":"C16112","definition":"Characteristics which are necessary to allow a subject to participate in a clinical study, as outlined in the study protocol. The concept covers inclusion and exclusion criteria.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1CC88111-1844-69E1-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-09-06","endDate":null,"createdBy":"SHIDED","dateCreated":"2006-09-06","modifiedBy":"ONEDATA","dateModified":"2006-09-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008525","version":"1","preferredName":"Eligibility","preferredDefinition":"trial-specific criteria that a patient must meet to be enrolled.","longName":"ELIG","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1EC3968-9F25-305A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1CC88111-1855-69E1-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-07-05","endDate":null,"createdBy":"SHIDED","dateCreated":"2006-09-06","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2644270","version":"1","preferredName":"051 Exclusion Clinical Trial Eligibility Criteria Type","preferredDefinition":"the type of clinical trial eligibility exclusion criteria for an AIDS Malignancy Consortium 051 protocol. ","longName":"051_EXCL_CTEC_TP","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"255","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Does the participant have concurrent active opportunistic infection (OI)","valueDescription":"Does the participant have concurrent active opportunistic infection (OI)","ValueMeaning":{"publicId":"2649450","version":"1","preferredName":"Does the participant have concurrent active opportunistic infection (OI)","longName":"2649450","preferredDefinition":"Does the participant have concurrent active opportunistic infection (OI)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"32651845-D921-3B9F-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-08","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-06-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"32653064-8258-372A-E044-0003BA3F9857","beginDate":"2007-06-08","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-06-08","modifiedBy":"ONEDATA","dateModified":"2007-06-08","deletedIndicator":"No"},{"value":"Does the participant have a history of prior or concurrent malignancy except for treated basal cell skin cancer or a cervical carcinoma in situ","valueDescription":"Does the participant have a history of prior or concurrent malignancy except for treated basal cell skin cancer or a cervical carcinoma in situ","ValueMeaning":{"publicId":"2649451","version":"1","preferredName":"Does the participant have a history of prior or concurrent malignancy except for treated basal cell skin cancer or a cervical carcinoma in situ","longName":"2649451","preferredDefinition":"Does the participant have a history of prior or concurrent malignancy except for treated basal cell skin cancer or a cervical carcinoma in situ","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"32651AA4-03CC-3BA1-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-08","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-06-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"32653064-8269-372A-E044-0003BA3F9857","beginDate":"2007-06-08","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-06-08","modifiedBy":"ONEDATA","dateModified":"2007-06-08","deletedIndicator":"No"},{"value":"Has the participant had acute treatment for an infection or other serious medical illness within 14 days prior to study entry; evidence of infiltrate, cavitation or consolidation on chest x-ray obtained before or at the time of the screening evaluation","valueDescription":"Has the participant had acute treatment for an infection or other serious medical illness within 14 days prior to study entry; evidence of infiltrate, cavitation or consolidation on chest x-ray obtained before or at the time of the screening evaluation","ValueMeaning":{"publicId":"2649452","version":"1","preferredName":"Has the participant had acute treatment for an infection or other serious medical illness within 14 days prior to study entry; evidence of infiltrate, cavitation or consolidation on chest x-ray obtained before or at the time of the screening evaluation","longName":"2649452","preferredDefinition":"Has the participant had acute treatment for an infection or other serious medical illness within 14 days prior to study entry; evidence of infiltrate, cavitation or consolidation on chest x-ray obtained before or at the time of the screening evaluation","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"32651C02-21B8-3BA3-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-08","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-06-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"32653064-827A-372A-E044-0003BA3F9857","beginDate":"2007-06-08","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-06-08","modifiedBy":"ONEDATA","dateModified":"2007-06-08","deletedIndicator":"No"},{"value":"Has the participant had antineoplastic treatment for KS (including chemotherapy, radiation therapy, biological therapy, or investigational therapy) within 4 weeks (6 weeks for nitrosourea or mitomycin-C) of study entry","valueDescription":"Has the participant had antineoplastic treatment for KS (including chemotherapy, radiation therapy, biological therapy, or investigational therapy) within 4 weeks (6 weeks for nitrosourea or mitomycin-C) of study entry","ValueMeaning":{"publicId":"2649453","version":"1","preferredName":"Has the participant had antineoplastic treatment for KS (including chemotherapy, radiation therapy, biological therapy, or investigational therapy) within 4 weeks (6 weeks for nitrosourea or mitomycin-C) of study entry","longName":"2649453","preferredDefinition":"Has the participant had antineoplastic treatment for KS (including chemotherapy, radiation therapy, biological therapy, or investigational therapy) within 4 weeks (6 weeks for nitrosourea or mitomycin-C) of study entry","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"32651DF6-7BB6-3C79-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-08","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-06-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"32653064-828B-372A-E044-0003BA3F9857","beginDate":"2007-06-08","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-06-08","modifiedBy":"ONEDATA","dateModified":"2007-06-08","deletedIndicator":"No"},{"value":"Has the participant had previous local therapy of any KS indicator lesion within 60 days, unless the lesion has progressed since treatment","valueDescription":"Has the participant had previous local therapy of any KS indicator lesion within 60 days, unless the lesion has progressed since treatment","ValueMeaning":{"publicId":"2649454","version":"1","preferredName":"Has the participant had previous local therapy of any KS indicator lesion within 60 days, unless the lesion has progressed since treatment","longName":"2649454","preferredDefinition":"Has the participant had previous local therapy of any KS indicator lesion within 60 days, unless the lesion has progressed since treatment","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"32651F9F-1D16-3BDA-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-08","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-06-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"32653064-829C-372A-E044-0003BA3F9857","beginDate":"2007-06-08","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-06-08","modifiedBy":"ONEDATA","dateModified":"2007-06-08","deletedIndicator":"No"},{"value":"Has the participant used any investigational drug or treatment up to 4 weeks before randomization","valueDescription":"Has the participant used any investigational drug or treatment up to 4 weeks before randomization","ValueMeaning":{"publicId":"2649477","version":"1","preferredName":"Has the participant used any investigational drug or treatment up to 4 weeks before randomization","longName":"2649477","preferredDefinition":"Has the participant used any investigational drug or treatment up to 4 weeks before randomization","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"32653064-82A6-372A-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-08","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-06-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"32651845-D9B2-3B9F-E044-0003BA3F9857","beginDate":"2007-06-08","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-06-08","modifiedBy":"ONEDATA","dateModified":"2007-06-08","deletedIndicator":"No"},{"value":"Does the participant have any known hypersensitivity to rapamycin or its derivatives or macrolide antibiotics","valueDescription":"Does the participant have any known hypersensitivity to rapamycin or its derivatives or macrolide antibiotics","ValueMeaning":{"publicId":"2649478","version":"1","preferredName":"Does the participant have any known hypersensitivity to rapamycin or its derivatives or macrolide antibiotics","longName":"2649478","preferredDefinition":"Does the participant have any known hypersensitivity to rapamycin or its derivatives or macrolide antibiotics","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"32651845-D99B-3B9F-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-08","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-06-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"32651845-D9C4-3B9F-E044-0003BA3F9857","beginDate":"2007-06-08","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-06-08","modifiedBy":"ONEDATA","dateModified":"2007-06-08","deletedIndicator":"No"},{"value":"Is the participant receiving treatment with agents or medications, other than antiretroviral drugs used to treat HIV infection, which would interfere with the metabolism or excretion of rapamycin","valueDescription":"Is the participant receiving treatment with agents or medications, other than antiretroviral drugs used to treat HIV infection, which would interfere with the metabolism or excretion of rapamycin","ValueMeaning":{"publicId":"2649479","version":"1","preferredName":"Is the participant receiving treatment with agents or medications, other than antiretroviral drugs used to treat HIV infection, which would interfere with the metabolism or excretion of rapamycin","longName":"2649479","preferredDefinition":"Is the participant receiving treatment with agents or medications, other than antiretroviral drugs used to treat HIV infection, which would interfere with the metabolism or excretion of rapamycin","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"32654166-B78E-3C12-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-08","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-06-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"32651845-D9D6-3B9F-E044-0003BA3F9857","beginDate":"2007-06-08","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-06-08","modifiedBy":"ONEDATA","dateModified":"2007-06-08","deletedIndicator":"No"},{"value":"Does the participant have a Grade III/IV cardiac disease as defined by the New York Heart Association criteria (e.g., congestive heart failure, myocardial infarction within 6 months of study)","valueDescription":"Does the participant have a Grade III/IV cardiac disease as defined by the New York Heart Association criteria (e.g., congestive heart failure, myocardial infarction within 6 months of study)","ValueMeaning":{"publicId":"2649480","version":"1","preferredName":"Does the participant have a Grade III/IV cardiac disease as defined by the New York Heart Association criteria (e.g., congestive heart failure, myocardial infarction within 6 months of study)","longName":"2649480","preferredDefinition":"Does the participant have a Grade III/IV cardiac disease as defined by the New York Heart Association criteria (e.g., congestive heart failure, myocardial infarction within 6 months of study)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"32653351-E34A-3C04-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-08","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-06-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"32651845-D9E8-3B9F-E044-0003BA3F9857","beginDate":"2007-06-08","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-06-08","modifiedBy":"ONEDATA","dateModified":"2007-06-08","deletedIndicator":"No"},{"value":"If the participant is female, is she pregnant or breast-feeding","valueDescription":"If the participant is female, is she pregnant or breast-feeding","ValueMeaning":{"publicId":"2649481","version":"1","preferredName":"If the participant is female, is she pregnant or breast-feeding","longName":"2649481","preferredDefinition":"If the participant is female, is she pregnant or breast-feeding","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"32655A77-934F-3C34-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-08","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-06-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"32651845-D9FA-3B9F-E044-0003BA3F9857","beginDate":"2007-06-08","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-06-08","modifiedBy":"ONEDATA","dateModified":"2007-06-08","deletedIndicator":"No"},{"value":"Does the participant have another severe and/or life-threatening medical disease","valueDescription":"Does the participant have another severe and/or life-threatening medical disease","ValueMeaning":{"publicId":"2649485","version":"1","preferredName":"Does the participant have another severe and/or life-threatening medical disease","longName":"2649485","preferredDefinition":"Does the participant have another severe and/or life-threatening medical disease","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"32652E60-3777-3C62-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-08","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-06-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"326487A2-3501-3CC7-E044-0003BA3F9857","beginDate":"2007-06-08","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-06-08","modifiedBy":"ONEDATA","dateModified":"2007-06-08","deletedIndicator":"No"},{"value":"Does the participant have an acute or known chronic liver disease (e.g., chronic active hepatitis, cirrhosis) (Participants with known Hepatitis C infection but with documentation of no or minimal fibrosis on liver biopsy may be enrolled)","valueDescription":"Does the participant have an acute or known chronic liver disease (e.g., chronic active hepatitis, cirrhosis) (Participants with known Hepatitis C infection but with documentation of no or minimal fibrosis on liver biopsy may be enrolled)","ValueMeaning":{"publicId":"2649484","version":"1","preferredName":"Does the participant have an acute or known chronic liver disease (e.g., chronic active hepatitis, cirrhosis) (Participants with known Hepatitis C infection but with documentation of no or minimal fibrosis on liver biopsy may be enrolled)","longName":"2649484","preferredDefinition":"Does the participant have an acute or known chronic liver disease (e.g., chronic active hepatitis, cirrhosis) (Participants with known Hepatitis C infection but with documentation of no or minimal fibrosis on liver biopsy may be enrolled)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"326487A2-34EA-3CC7-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-08","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-06-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"326487A2-3513-3CC7-E044-0003BA3F9857","beginDate":"2007-06-08","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-06-08","modifiedBy":"ONEDATA","dateModified":"2007-06-08","deletedIndicator":"No"},{"value":"Has the participant had major surgery within 2 weeks prior to study entry","valueDescription":"Has the participant had major surgery within 2 weeks prior to study entry","ValueMeaning":{"publicId":"2649483","version":"1","preferredName":"Has the participant had major surgery within 2 weeks prior to study entry","longName":"2649483","preferredDefinition":"Has the participant had major surgery within 2 weeks prior to study entry","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"32654D65-BEE6-3F71-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-08","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-06-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"326487A2-3525-3CC7-E044-0003BA3F9857","beginDate":"2007-06-08","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-06-08","modifiedBy":"ONEDATA","dateModified":"2007-06-08","deletedIndicator":"No"},{"value":"Has the participant had systemic corticosteroid treatment, other than replacement doses","valueDescription":"Has the participant had systemic corticosteroid treatment, other than replacement doses","ValueMeaning":{"publicId":"2649482","version":"1","preferredName":"Has the participant had systemic corticosteroid treatment, other than replacement doses","longName":"2649482","preferredDefinition":"Has the participant had systemic corticosteroid treatment, other than replacement doses","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"32651AA4-03EC-3BA1-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-08","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-06-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"326487A2-3537-3CC7-E044-0003BA3F9857","beginDate":"2007-06-08","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-06-08","modifiedBy":"ONEDATA","dateModified":"2007-06-08","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008525","version":"1","preferredName":"Eligibility","preferredDefinition":"trial-specific criteria that a patient must meet to be enrolled.","longName":"ELIG","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1EC3968-9F25-305A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2177853","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"Type","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C16D625D-02B6-1907-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-07-09","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-07-09","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"313BA07B-4088-5AFF-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-05-10","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-05-24","modifiedBy":"SHIDED","dateModified":"2011-04-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"Exclusion Criteria","type":"Preferred Question Text","description":"Exclusion Criteria","url":null,"context":"CTEP"}],"origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"32656BC4-90D3-412E-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-08","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-06-08","modifiedBy":"CAMPBELB","dateModified":"2011-11-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}